Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 250 mg, 500 mg and 750 mg. Levetiracetam Tablets are the generic version of UCB Pharma’s Keppra.

continue reading.....

SurModics, Inc. announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc., a drug delivery company specializing in injectable, biodegradable sustained release formulations.

continue reading.....

In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.

continue reading.....

Three common ingredients in multivitamins, vitamins B6 and B12 and folic acid, had no significant effect on the risk for cancer in women, who were observed for an average of 7.3 years.
Medscape Medical News

continue reading.....

A combination of sertraline and cognitive behavioral therapy may offer children with anxiety disorders the best chance for a positive outcome, but a single line of treatment is still effective.
Medscape Medical News

continue reading.....

A prominent psych nurse tackles controversial topics ranging from the US presidential election to workplace violence.

Medscape Med Students

continue reading.....

A decline in deaths from MI in recent decades appears to have been accompanied by an increase in the incidence of heart failure, according to a new analysis from the Framingham Heart Study. The likely explanation is that sicker patients, who would have died from MI in earlier years, are now surviving but going on to develop HF, say the researchers.
Heartwire

continue reading.....

PITTSBURGH, November 04, 2008 /PRNewswire-FirstCall/ — Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application…

continue reading.....

PITTSBURGH, November 04, 2008 /PRNewswire-FirstCall/ — Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application…

continue reading.....

The U.S. Supreme Court on Monday will hear opening arguments in Wyeth v. Levine, a case that could determine whether patients have the ability to file product liability lawsuits against pharmaceutical companies in state courts, the

continue reading.....